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Introduction 
Hepatitis E virus (HEV) is responsible for a faecal-oral 
transmitted disease with the clinical characteristics of 
acute hepatitis, already known as non-A, non-B and non-
C hepatitis. Hepatitis E was not recognized as a distinct 
human disease until 1980; the highest rates of infection 
occur in regions where low standards of hygiene promo-
te virus transmission, especially where faecal contamina-
tion in drinking water or food is common [1]. However, 
sporadic cases of hepatitis E have also been reported in 
industrialized countries, including Italy, and serological 
surveys suggest the diffusion of strains of hepatitis E of 
low pathogenicity [2-6]. The worldwide confirmation of 
anti-HEV in the sera of different animal species, (non-
human primates, pigs, bovines, sheep, poultry, dogs, cats 
and wild animals), has suggested the hypothesis that these 
animals could be infected by HEV-like viruses and that 
they may act as a reservoir for the infection [3, 4, 7, 8]; 
at the same time another hypothesis suggests that some 
human cases reported in literature are to be considered of 
zoonotic origin [9]. This hypothesis is reinforced by the 
evidence of cases of food-borne HEV transmission de-
scribed in humans after consuming raw or undercooked 
meat from wild boars or organs from pigs [10-12] and 
also from a recent case of human hepatitis E transmitted 
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via contact with a pet pig in Vietnam [13]. This disease 
is today considered an emergent zoonosis and could, in 
the future, be treated as a professional disease. The aim 
of this study was to determine the prevalence of HEV 
immunoglobulin (IgG anti-HEV) in blood donors and 
workers at zoonotic risk, in order to evaluate whether 
occupation may be a potential risk of infection, and to 
study HEV-RNA prevalence in swine from different 
Sardinian farms for evaluating any possible involvement 
of these animals in transmission of the virus.
Material and methods
Human samples 
In the first six months of 2008, 532 persons (389 males 
and 143 females) of whom 402 blood donors and 130 
workers at zoonotic risk (35 abattoir workers; 95 labo-
ratory workers exposed to biological swine material) 
were enrolled.
All the subjects had given informed consent to take part 
in this work. The study was conducted in compliance 
with the Helsinki Declaration and with Law Decree n. 
196/2003, article 24 (Code for the protection of personal 
data).
Summary 
Introduction.	The	aim	of	this	study	was	to	determine	the	sero-
prevalence	of	anti-HEV	antibodies	in	humans	sera	and	to	study	
HEV	prevalence	in	swine	from	different	Sardinian	farms,	testing	
viral	HEV-RNA	in	bile	samples.
Methods.	In	the	first	six	months	of	2008,	532	subjects	of	whom	
402	 blood	 donors	 and	 130	 workers	 at	 zoonotic	 risk,	 were	
enrolled.	 Anti-HEV	 were	 determined	 with	 an	 enzyme	 linked	
immunosorbent	 assay	 (ELISA).	 In	 positive	 subjects,	 RNA	 was	
extracted	and	tested	by	RT-Nested-PCR.
From	July	2006	to	March	2007,	95	bile	samples	were	collected	
from	randomly	selected	pigs.	RNA	was	extracted	from	250	µl	of	
bile	and	tested	by	RT-Nested-PCR.
Results.	 The	 overall	 prevalence	 of	 anti-HEV	 antibodies	 was	
4.3%;	5.0%	among	blood	donors	and	2.3%	among	workers	at	
zoonotic	risk,	with	no	statistically	significant	differences	between	
sex,	age	classes	and	occupation.	The	search	for	HEV-RNA	in	the	
subjects	positive	for	antibodies,	gave	negative	results.
HEV	 genome	 was	 detected	 in	 6	 of	 the	 95	 swine	 bile	 samples	
tested.	Sequences	were	clustered	within	the	genotype	3	and	are	
edited	on	GenBank	under	accession	number:	from	FJ850960	to	
FJ850962	and	from	FJ883000	to	FJ883002.
Discussion.	The	overall	prevalence	of	anti-HEV	shows	that	the	
virus	circulates	without	giving	origin	to	cases	of	acute	hepatitis.	
The	 low	prevalence	value	 found	in	workers	at	zoonotic	risk	do	
not	 apparently	 support	 the	 hypothesis	 of	 professional	 risk.	 In	
this	study,	HEV-RNA	was	isolated	from	pigs	in	Sardinia	for	the	
first	time	confirming	the	role	of	swine	as	HEV	reservoir	and	the	
possibility	of	virus	transmission	to	humans.
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Samples were divided into 4 age classes (20-29, 30-39, 
40-49 and ≥ 50 years). The occupations of the blood 
donors are shown in Table I.
A commercially available diagnostic anti-HEV ELISA 
kit (Human anti-HEV ELISA) manufactured by Dia-
gnostic Bioprobes Srl, Milan, Italy was used to detect 
anti-HEV antibodies in the serum samples. The ELISA 
test is based on the use of synthetic antigens correspon-
ding to the immunodominant epitopes found in oRF2 
and oRF3 of the Mexico strain and the Burma strain. 
The assay, a third-generation ELISA for the qualitati-
ve determination of IgG antibodies to HEV in human 
serum, was performed according to the manufacturer’s 
instructions where it presents 99.5% specificity and 
100% sensitivity.
In positive subjects, RNA was extracted from 200 µl of 
sera by using High Pure Viral Nucleic Acid Kit (Roche) 
according to the manufacturer’s instructions.
Swine samples
From July 2006 to March 2007, 95 bile samples were 
collected from randomly selected pigs, aged 8-9 mon-
ths (fatteners) during the slaughtering process; a bile 
sample was withdrawn from each animal through the 
gallbladder wall using a sterile syringe (used once and 
then discarded), and stored at -20°C until processing. 
Animals belonged to six different Sardinian intensive 
breeding farms. All the sampled pigs appeared to be 
clinically healthy. RNA was extracted from 250 µl of 
bile using TRIZoL LS reagent (Invitrogen, Carlsbad, 
CA, USA) according to the manufacturer’s instruc-
tions [14].
RT-Nested-PCR
RNA reverse transcription (RT) and first PCR reaction 
were conducted using a Superscript III onestep RT-
PCR System with Platinum Taq DNA polymerase (In-
vitrogen) according to the manufacturer’s instructions. 
The RT-PCR reaction was conducted in a MyCycler 
(Bio-Rad, Hemel Hempstead, UK) thermal cycler un-
der the following conditions: 50°C for 30 min for RT, 
followed by 25 cycles of denaturation at 94°C for 10 s, 
annealing at 49°C for 30 s, elongation at 68°C for 1 min 
and a final elongation at 68°C for 7 min. Nested PCR 
was conducted using a Platinum PCR Supermix (Invi-
trogen) according to the manufacturer’s instructions, 
following the subsequent thermal conditions: initial 
denaturation at 94°C for 2 min followed by 35 cycles 
of denaturation at 94°C for 30 s, annealing at 50°C for 
30 s, elongation at 72°C for 2 min and a final elongation 
at 72°C for 7 min. 
For RT-PCR and Nested PCR, sets of degenerate pri-
mers, HEVoRF2con-a1/HEVoRF2-con-S1 and HE-
VoRF2con-a2/HEVoRF2con-S2 [15], amplifying a 
154 bp region of the HEV open reading frame 2 (oRF2) 
were used. Amplified products were visualized in a 
2% agarose gel stained with SybrSafe DNA Gel Stain 
(Invitrogen) and visualized by a blue-light transillu-
minator. Positive samples	were tested with a different 
set of degenerate primers;3156N, 3157N, 3158N and 
3159N [16], amplifying a 348 bp sequence under the 
same run conditions.
Capillary sequencing procedure 
PCR products were sequenced by a conventional capil-
lary sequencing procedure [17]. The sequence reaction 
was performed in 10 µl volumes using a Big Dye chem-
istry Kit (Perkin-Elmer Applied Biosystems Division, 
Foster City, Calif) according to the manufacturer’s in-
structions. The mixture contained: 5 µM of each primer, 
2 mM MgCl2, and 1,5 µl of purified PCR products. The 
cycling parameters were 25 cycles consisting of dena-
turation at 96°C for 10 sec, 50°C for 5 sec, 60°C for 4 
sec. The sequences were determined with an ABI Prism 
310 automatic sequencer (Applied Biosystems Foster 
City, Calif.). The results were edited and analyzed by 
the Basic Local Alignment Search Tool (http://www.
ncbi.nlm.nih.gov/BLAST/).
Sequence alignment and phylogenetic 
analysis
HEV capsid protein gene sequences of all the isolates 
were compared with those of previously described 
strains of HEV deposited in the NCBI GenBank. Nu-
cleotide sequences were aligned using CLUSTAL X 
version 1.83.9 A phylogenetic tree was constructed by 
GeneBee-NET:Internet-based server with TreeTop-Phy-
logenetic Tree Prediction [18, 19]. A sequence variation 
analysis was performed using the MegAlign program 
from DNASTAR. A helpful motif sequence, for a com-
parative clear phylogenetic analysis, was only obtained 
for 3/6 samples, corresponding to GenBank Accession 
numbers from FJ850960 to FJ850962. The remaining 
samples showed a scant DNA fragment size by sequenc-
ing for comparative analysis. 
Statistical analysis 
Frequencies for the different groups were expressed 
with the respective confidence intervals at 95% (CI 
95%) according to a Poisson distribution, and average 
values with relative standard errors (ES). Significance 
of differences of anti-HEV between the groups’ age 
and sex was calculated by the chi square test. Statisti-
cal significance was established at p < 0.05. The Man-
tel-Haenszel test was used to assess the association of 
HEV between blood donors and workers at zoonotic 
risk, adjusted for the potential confounding effect of 
gender and age.
Tab. I. blood donors occupations.
Occupation N. subjects
1. Clerk workers 220
2. health workers 20
3. military personnel 30
4. Stud/housewives/senior citizens 40
5. Freelance 37
6. unknown 54
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Results 
Human subjects 
The overall prevalence of anti-HEV was 4.3% (23/532 
CI 95% 2.7-5.8); 5.0% (20/402 CI 95% 2.3-5.9) among 
blood donors and 2.3% (3/130, CI 95% 0.2-5.0) among 
abattoir workers and /or laboratory workers exposed to 
biological swine materials	(Fig. 1). 
No statistically significant differences (p > 0.05) in 
anti-HEV prevalence were detected between sex and 
age classes; similarly, we did not find any differences in 
anti-HEV prevalence according to occupation (Tab. II). 
Finally, the search for the genome of the virus in the 23 
subjects, testing positive for antibodies, gave negative 
results.
HEV prevalence in swines 
HEV genome was detected in 6 of the 95 bile samples 
tested (6.3% CI 95% 1.4-11.2).
Sequences obtained from these RT-PCR products, 
have been deposited with Genbank accession numbers 
from FJ850960 to FJ850962 and from FJ883000 to 
FJ883002.
Phylogenetic analysis 
The phylogenetic tree (on 3 samples) was generated 
using GeneBee software from HEV caspid protein gene 
sequences obtained with swine positive samples. These 
results (Fig. 2) showed that at least 2 Sardinian isolates 
(isolates n. 5 and n. 10) belonged to a unique lineage 
and similar comparative distances were found with 
European (France, Netherlands) strains, thus indicating 
a possible virus spread between these areas. Swine se-
quences were clustered within the genotype 3. 
Discussion
The overall prevalence of anti-HEV antibodies appears 
to be in agreement with that noticed in a previous 
study conducted in Italy in the ’90s (4.3% vs 5.3% 
p > 0.05) [20]. 
However these values are still lower compared to preva-
lence found in other countries with a similar socio-eco-
nomic and health status, in which Hepatitis E is general-
ly a sporadic disease but where sometimes lethal cases 
of fulminant Hepatitis have also been reported [21, 22]. 
Furthermore, the fact that a number of European coun-
tries, such as Germany, have classified Hepatitis E as 
a notifiable infectious disease for several years, means 
that they have well defined case records [23] whereas 
Italy only started to do so in 2008. The SEIEVA (In-
tegrated Epidemiological system for Acute Viral He-
patitis), coordinated by the Istituto	Superiore	di	Sanità 
Fig. 1. prevalence of anti-hev among blood donors and workers 
at zoonotic risk.
Tab. II. Anti-hev prevalence between age classes, sex and subject 
category.
Age group pos No. subjects % pos CI 95%
20-29 2 69 2.9 1.9-7.0
30-39 6 170 3.5 0.7-6.5
40-49 9 193 4.7 1.7-8.0
≥ 50 6 100 6.0 1.4-11.3
total 23 532 4.3 2.7-6.3
p = 0.72
Gender
females 5 143 3.5 0.5-6.5
males 18 389 4.6 2.5-6.7
p = 0.57
Subject category
blood donor 20 402 5.0 2.3-5.9
workers at zoonotic 
risk
3 130 2.3 0.2-5.0
p = 0.31
Fig. 2. phylogenetic tree showing the relationship of 3/6 hev iso-
lates from italy (Sardinia) and others capsid sequences described 
in dnA data bank (genbank). For the remaining 3 isolates, it was 
not possible to obtain a sufficient dnA sequence for comparative 
analysis.
    GenBank Accession
italy 5 FJ850961
italy 10 FJ850962
France 1-h eu495231
France 2-h eF061403
France 3-h eu116337
nether. 1h AF336290
korea 1-S AF516179
uSA 3-h AF060668
thail. 1-S Ay858896
uSA 2-h Ay927767
uSA 1-S Ay927748
mexico 1-S Ay858937
Japan 4-S Ab194508
Japan 3-h Ab082565
Japan 6-S Ab094328
Japan 1-h Ab434144
Japan 2-h eF061403
Canada 1-S dQ859995
Japan 5-S Ab112743
italy 1 FJ850960
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(Italy’s National Health Service) has included Hepatitis 
E among notifiable infectious diseases. Cases are repor-
ted on the basis of the presence of the serological marker 
for Hepatitis E identified in the IgM anti-HEV. To the 
present day, the cases of HEV reported in the period 
between 2007 and 2009 have been 37, equal to 1% of 
the total cases of acute Hepatitis. The main reported risk 
factor was travel to endemic areas, in particular Bangla-
desh (11/20) and India (7/20), and the consumption of 
water from wells or springs (SEIEVA 2009).
The rate of 4.8% in blood donors is, in any case, lower 
than data reported by European and international li-
terature which counts frequencies from 16% up to 
20.6% [24, 25.] In this category defined as a healthy 
population par excellence, it is difficult to identify any 
risk factor for the infection: none of the 20 anti-HEV 
positive subjects carry out a working activity which 
could be defined as “risky” (handling animals or con-
tact with animals), even though domestic handling of 
meat could be a risk factor through secondary conta-
mination of food consumed raw (vegetables, fruit). 
The source of the relativity high anti-HEV prevalence 
in blood donors is still difficult to investigate, unless 
a study is made of common practices such as the use 
of water from natural sources (uncontrolled) and the 
simultaneous use of the same utensils (chopping boards, 
knives) in the kitchen in the preparation of raw meat 
and other foods. The prevalence of 2.3% found in the 
group of people working with biological material of 
animal origin including swine, is low compared to the 
anti-HEV frequency reported in other studies carried 
out in veterinarians and farmers working with pigs in 
other countries [26, 27]. The data obtained in Sardinia 
seems to suggest that handling meat from pigs and 
diagnostic work on biological matrices from the same 
species does not apparently represent an evident risk 
of infection: this evidence must however be associated 
with the rather low percent of HEV RNA positive bile 
samples observed in Sardinian swine, which might 
suggest a reduced circulation of virus in these animals 
as opposed to other studies in both continental Italy and 
other European countries [28-30].
In any case, the detection of the virus genome in Sar-
dinian pig bile confirms the role of swine as an HEV 
reservoir and the possibility of virus transmission to hu-
mans, probably in different ways, as a result of different 
territorial realties. This datum is enforced by a study 
carried out in 2004 on swine sera coming from different 
Sardinian pig farms showing a prevalence of anti-HEV 
antibodies of 27% (41/152) (results not published), thus 
enforcing the zoonosys hypothesis.
The epidemical situation is not of easy reading; it could 
be motivated by environmental contamination by re-
fluents in some rural areas near swine farms associated 
with a low virulence of HEV virus.
As regards the risk of virus transmission through the 
consumption of raw or undercooked foods, numerous 
cases have been reported in literature, confined to coun-
tries where HEV is present in an endemic form and can 
result in acute hepatitis [11, 12]. Sardinian food habits 
are somewhat different: in fact although there is a large 
consumption of pork, it is always eaten well cooked. 
In this study, HEV RNA was isolated from pigs in 
Sardinia for the first time and the capsid sequences 
were characterized. Phylogenetic analysis suggests that 
at least 2 Sardinian isolates belong to a unique cluster 
characterized by frequencies philogenetically corre-
lated with European strains (France and Holland), 
highlighting possible virus diffusion between these geo-
graphic areas (Fig. 2).
Breeding stock from these European regions are fre-
quently imported into Sardinian pig farms and commer-
cial exchanges with European farms are also common 
practice. All frequencies belonged to genotype 3 which 
is prevalent in Europe [31, 32]. It is now common 
knowledge that both pigs and wild boars represent the 
most important reservoir of HEV virus in the European 
and North-American epidemical situation [33, 34]. The-
se results, together with the fact that the pigs appeared 
clinically healthy, raise the hypothesis that HEV infec-
tion may be subclinical for them.
This is the first description of HEV infection in Sar-
dinian swine and further studies are needed to better 
assess their role in the circulation of the virus.
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